Recently Published Articles
2023 2022 2021 2020 2019 2018 2017 2016
Guselkumab, a Selective Interleukin-23 p19 Subunit Inhibitor, Resolves Dactylitis in Patients With Active Psoriatic Arthritis: Pooled Results Through Week 52 From Two Phase 3 Studies. McGonagle D, McInnes IB, Deodhar A, Schett G, Shawi M, Chakravarty SD, Kollmeier AP, Xu XL, Sheng S, Xu S, Ritchlin CT, Rahman P, Mease PJ. ACR open rheumatology.. 2023 Mar 7; Epub 2023 Mar 07.
Near-Infrared Imaging of Indocyanine Green Identifies Novel Routes of Lymphatic Drainage from Metacarpophalangeal Joints in Healthy Human Hands. Kenney HM, Dieudonne G, Yee S, Maki JH, Wood RW, Schwarz EM, Ritchlin CT, Rahimi H. Lymphatic research and biology.. 2023 Feb 20; Epub 2023 Feb 20.
Food protein-induced enterocolitis syndrome: Healthcare utilization and referral patterns among a pediatric cohort. Pier J, Bingemann T, Badwal J, Rosloff D, Pasha M, Wang H, Lomas JM, Järvinen KM. . 2023 4:1102410. Epub 2023 Feb 10.
Multidomain Efficacy and Safety of Guselkumab Through 1 Year in Patients With Active Psoriatic Arthritis With and Without Prior Tumor Necrosis Factor Inhibitor Experience: Analysis of the Phase 3, Randomized, Placebo-Controlled DISCOVER-1 Study. Ritchlin CT, Deodhar A, Boehncke WH, Soriano ER, Kollmeier AP, Xu XL, Zazzetti F, Shawi M, Jiang Y, Sheng S, Helliwell PS. ACR open rheumatology.. 2023 Feb 10; Epub 2023 Feb 10.
The Need for Required Stock Epinephrine in All Schools: A Work Group Report of the AAAAI Adverse Reactions to Foods Committee. Russell AF, Bingemann TA, Cooke AT, Ponda P, Pistiner M, Jean T, Nanda A, Jobrack J, Hoyt AEW, Young MC. The journal of allergy and clinical immunology. In practice.. 2023 Jan 27; Epub 2023 Jan 27.
Educating the Clinician: Importance of Black Participation in Lupus Clinical Trials. Anandarajah, A. Rheum Advisor. 2023 Jan.
Immune Dysregulation. Long, A, Kleiner, A, Looney, R. J Allergy Clin Immunol. 2023 Jan:151(1):70-80.
The effect of guselkumab on inhibiting radiographic progression in patients with active psoriatic arthritis: study protocol for APEX, a Phase 3b, multicenter, randomized, double-blind, placebo-controlled trial." Ritchlin CT, Coates LC, Mease PJ, van der Heijde D, Song J, Jiang Y, Shawi M, Kollmeier AP, Rahman P. Trials.. 2023 Jan 10; 24(1):22. Epub 2023 Jan 10.